Literature DB >> 16151393

Upping the ante on antibodies.

Monya Baker.   

Abstract

The current generation of antibodies has done more than make a few companies rich. It has laid the groundwork for ambitious companies to move to maturity.

Mesh：

Substances：

Year:  2005        PMID： 16151393     DOI： 10.1038/nbt0905-1065

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


  20 in total

1.  The future of monoclonal antibody technology.

Authors:  Alexander Zider; Donald L Drakeman
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies.

Authors:  Carlos Vaccaro; Roger Bawdon; Sylvia Wanjie; Raimund J Ober; E Sally Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Monoclonal antibodies from plants: a new speed record.

Authors:  Andrew Hiatt; Michael Pauly
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

4.  Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies.

Authors:  Xiaoling Wang; Tapan K Das; Satish K Singh; Sandeep Kumar
Journal:  MAbs       Date:  2009-05-29       Impact factor: 5.857

Review 5.  Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

Authors:  C Andrew Boswell; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2007-06-08       Impact factor: 2.408

6.  Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.

Authors:  P Macor; E Secco; N Mezzaroba; S Zorzet; P Durigutto; T Gaiotto; L De Maso; S Biffi; C Garrovo; S Capolla; C Tripodo; V Gattei; R Marzari; F Tedesco; D Sblattero
Journal:  Leukemia       Date:  2014-06-06       Impact factor: 11.528

7.  Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice.

Authors:  Pablo D Becker; Nicolas Legrand; Caroline M M van Geelen; Miriam Noerder; Nicholas D Huntington; Annick Lim; Etsuko Yasuda; Sean A Diehl; Ferenc A Scheeren; Michael Ott; Kees Weijer; Heiner Wedemeyer; James P Di Santo; Tim Beaumont; Carlos A Guzman; Hergen Spits
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

8.  Efficient antibody production upon suppression of O mannosylation in the yeast Ogataea minuta.

Authors:  Kousuke Kuroda; Kazuo Kobayashi; Yoshinori Kitagawa; Taishiro Nakagawa; Haruhiko Tsumura; Toshihiro Komeda; Daisuke Shinmi; Eiji Mori; Kazuhiro Motoki; Kazumi Fuju; Teruyuki Sakai; Koichi Nonaka; Takeshi Suzuki; Kimihisa Ichikawa; Yasunori Chiba; Yoshifumi Jigami
Journal:  Appl Environ Microbiol       Date:  2007-11-26       Impact factor: 4.792

9.  Molecularly defined antibody conjugation through a selenocysteine interface.

Authors:  Thomas Hofer; Lauren R Skeffington; Colby M Chapman; Christoph Rader
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

10.  Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution.

Authors:  Renuka Thirumangalathu; Sampathkumar Krishnan; Margaret Speed Ricci; David N Brems; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.